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Dyskerin is a component of small nucleolar ribonucleoprotein complexes and acts as a pseudouridine
synthase to modify newly synthesized ribosomal, spliceosomal, and possibly other RNAs. It is encoded by the
DKC1 gene, the gene mutated in X-linked dyskeratosis congenita, and is also part of the telomerase complex.
The yeast ortholog, Cbf5, is an essential protein, but in mammals the effect of dyskerin ablation at the cellular
level is not known. Here we show that mouse hepatocytes can survive after induction of a Dkc1 deletion. In the
absence of dyskerin, rRNA processing is inhibited with the accumulation of large precursors, and fibrillarin
does not accumulate in nucleoli. A low rate of apoptosis is induced in the hepatocytes, which show an induction
of the p53-dependent cell cycle checkpoint pathway. Signs of liver damage including an increase in serum
alanine aminotransferase activity and a disordered structure at the histological and macroscopic levels are
observed. In response to carbon tetrachloride administration, when wild-type hepatocytes mount a rapid
proliferative response, those without dyskerin do not divide. We conclude that hepatocytes can survive without
dyskerin but that the role of dyskerin in RNA modification is essential for cellular proliferation.
Modification of specific bases of newly synthesized ribo-
somal and spliceosomal RNAs is an early posttranscriptional
event and is carried out by specialized nucleolar complexes, the
snoRNPs. There are 2 classes of snoRNPs, H/ACA RNPs,
which pseudouridylate specific uridines, and C/D RNPs, which
catalyze the methylation of specific residues. In both cases the
complexes consist of a guide RNA and 4 proteins (1, 12, 55). In
the case of H/ACA RNPs the guide RNA is an H/ACA
snoRNA which uses base pairing to guide the complex to
specific uridines in the nascent target RNA (14). The 4 pro-
teins are dyskerin (20, 35), NOP10 (21), NHP2 (21, 52), and
GAR1 (16); dyskerin is the pseudouridine synthase (29). RNA
modification is an ancient process, and the snoRNP proteins
are highly conserved. Despite this, the role of RNA modifica-
tions is not clearly understood. Pseudouridines are frequently
found in regions of rRNAs that are functionally important, and
they are thought to increase the stability of folded domains.
Though depletion of individual snoRNAs does not seem to
affect growth in yeast, the yeast ortholog of dyskerin, Cbf5, is
essential (26). Interestingly, mutations that render Cbf5 unable
to form pseudouridine permit cell survival but lead to a severe
reduction in ribosome synthesis (56).
H/ACA snoRNPs have other cellular functions as well as
pseudouridylation of rRNA (34). Some are involved in cleav-
age of rRNA precursors, and a class of H/ACA RNPs is local-
ized in the Cajal body rather than the nucleolus (9). These
“scaRNPs” are characterized by the presence in the scaRNA
of a conserved Sca motif (43) and function in the modification
of snRNAs (9), the small RNAs essential for pre-mRNA splic-
ing. In vertebrates the 3 domain of telomerase RNA, TERC,
is an H/ACA RNA (36), and this RNA, which provides the
template for synthesis of telomere repeats, is found in an RNP
complex with the same 4 proteins found in other snoRNPs as
well as telomerase reverse transcriptase and other proteins (13,
37, 48, 49). TERC RNA contains a Sca motif and is found in
Cajal bodies (25). Finally, some H/ACA RNPs have no known
function, their integral RNA having no known target. In one
case of such an orphan RNA its expression appears to be
restricted to the brain (8), opening up the possibility that
H/ACA RNAs can effect tissue-specific gene expression.
In Drosophila the dyskerin ortholog, minifly, is essential for
viability (15). Minifly mutations that retain some function lead
to small size, developmental delay, and reduced fertility
through defects in pseudouridylation and rRNA processing. In
mice complete knockout of the gene encoding dyskerin, Dkc1,
is embryonic lethal (19). In humans hypomorphic mutations in
the DKC1 gene on the X chromosome cause X-linked dysker-
atosis congenita (DC) (20, 28), an inherited bone marrow
failure syndrome characterized by the presence of hypo- and
hyperpigmentation, nail dystrophy, and mucosal leukoplakia
(50). Interestingly most of the pathological effects of the dys-
kerin mutations in DC patients seem to be due to problems
with telomere maintenance, since other forms of DC are
caused by mutations in other components of telomerase (51)
and biochemical investigations show a decrease in levels of
telomerase RNA, TERC, and telomerase activity but no de-
tectable change in rRNA processing or snoRNA metabolism
(53, 54). Mice, or mouse embryonic stem (ES) cells, containing
dyskerin amino acid changes that cause DC in humans so far
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show variable effects, some having decreased Terc RNA and
telomerase and mild defects in ribosome biogenesis (18, 38).
So far none of these mice has shown the pathological features
of DC, probably due to the fact that laboratory mice have very
long telomeres. In the complete absence of telomerase, mice
show no striking defects in the first generation but they pass
shortened telomeres to their offspring and generation 3 and
later generations show some features similar to those seen in
DC (3, 32). Recently we described a mouse line produced by
gene targeting which contained a copy of a human mutation
consisting of a 3 truncation of the Dkc1 gene, encoding a
protein with the last 21 amino acids (aa) missing (17). These
mice showed the slower growth of proliferative tissues charac-
teristic of DC. The slow growth was dependent on telomerase,
independent of telomere length, and associated with the accu-
mulation of DNA damage.
In mammalian cells, though dyskerin is essential for embry-
onic development, it is not known if it is essential for cell
survival or for cell division. In this paper we used an inducible
knockout strategy to delete the Dkc1 gene in adult mice and
found that while most tissues were reconstituted from cells that
had escaped the deletion the liver survived for weeks with the
majority of its cells containing the deleted gene. This gave us
the opportunity of studying mammalian cells that did not con-
tain dyskerin. These cells, despite their long-term survival,
were defective in rRNA synthesis, showed signs of a cell cycle
checkpoint response and the induction of apoptosis, and were
defective in cell division following liver injury. We conclude
that dyskerin is not required for cell survival but is essential for
cell division.
MATERIALS AND METHODS
Generation of Dkc1 conditional KO mice. The generation of the Dkc1lox allele
in C57BL/6 mice has been previously described (19). Mice carrying the Alb-Cre
transgene (42) and mice carrying the Mx1-Cre transgene were obtained from the
Jackson Laboratory (Bar Harbor, ME). Homozygous floxed dyskerin mice were
bred to Alb-Cre mice, and male mice (9 weeks old unless specified) which carry
a floxed dyskerin allele and Alb-Cre were selected for study (Dkc1loxTg:AlbCre,
referred to as knockout [KO] mice). For all experiments and analysis, mice with
the genotype Dkc1lox or Dkc1Tg:AlbCre were used as controls and are referred
to as wild type (WT) throughout. Similarly, male Dkc1loxTg:Mx1Cre mice were
selected for study (KO) along with their Dkc1lox or Dkc1Tg:Mx1Cre littermates
(WT). For induction of the Mx1-Cre transgene, mice (5 weeks old) were injected
with poly(I:C) (250 g intraperitoneally [i.p.]) every other day for a total of 3
injections. Mice were sacrificed 4 weeks after the last injection.
All experiments on mice were performed under the strict guidelines of the
National Institutes of Health and the Institutional Animal Use and Care Com-
mittee at Washington University. Age- and sex-matched conditional knockout
mice and control littermates were weighed and sacrificed (n  3 to 5). Livers
were isolated, and the wet weights were recorded to calculate the liver weight-
to-body weight ratio. Livers were also used for DNA and RNA isolation, protein
extraction, histology, and immunohistochemistry.
CCl4 treatment. Nine-week-old male Dkc1loxTg:AlbCre mice and controls were
subjected to carbon tetrachloride (CCl4) (Sigma-Aldrich, St. Louis, MO) treat-
ment (2 g/g of body weight; i.p.) to induce liver damage. Equal numbers of KO
and WT mice were sacrificed by CO2 asphyxiation at different times after CCl4
treatment. Mice were injected i.p. with 2.5 mg/mouse bromodeoxyuridine (BrdU;
Sigma-Aldrich, St. Louis, MO) 1 h before sacrifice. The regenerating livers were
harvested and used for DNA isolation, total RNA isolation, protein extraction,
and paraffin embedding.
DNA, RNA, and protein analysis. Liver tissues from the WT and KO mice
were used for isolating and purifying DNA and RNA. DNA was isolated by the
standard sodium dodecyl sulfate (SDS)-proteinase K method. Southern blotting
to distinguish between the Dkc1lox and the Dkc1DC1 alleles was performed as
described previously (19). RNA was isolated using Trizol (Invitrogen, Carls-
bad, CA).
Nuclear protein extraction was performed using NE-PER nuclear and cyto-
plasmic extraction reagents (Pierce, Rockford, IL). Twenty micrograms of pro-
tein was resolved by SDS-polyacrylamide gel electrophoresis (PAGE) analysis
and transferred to a Hybond-ECL nitrocellulose membrane (GE Healthcare,
Piscataway, NJ). Antibodies were detected by ECL plus Western blotting detec-
tion reagents (GE Healthcare) and visualized by autoradiography. Primary an-
tibodies used in this study were polyclonal antiserum to 2 dyskerin peptides,
DCSNPLKREIGDYIR (aa 74 to 88) and GLLDKHGKPTDNTPAC (aa 382 to
396  C) (38); a polyclonal antiserum against the dyskerin peptide DRKPLQE
DDVAEIQHA (aa 18 to 33); anti-TATA box binding protein (1:2,000; Abcam,
Cambridge, MA); anti-p53 (1:1,000; Abcam); anti-p21 (1:200; Abcam); and an-
tifibrillarin (1:1,000; Abcam). The secondary antibody was either horseradish
peroxidase-conjugated goat anti-mouse antibody (1:10,000; Abcam) or horserad-
ish peroxidase-conjugated goat anti-rabbit antibody (1:10,000; Abcam).
Pre-rRNA analysis. Pre-rRNA analysis by Northern blotting was as described
previously (44) using synthetic oligonucleotide DNA probes. RNA (10 g) was
electrophoresed in 1% (wt/vol) agarose-formaldehyde gels and blotted to Hybond-
N membranes (GE Healthcare) overnight. Oligonucleotides (10 pmol) were
end labeled with [-32P]ATP and T4 polynucleotide kinase (Fisher, Pittsburgh,
PA). The temperature of hybridization and washing was determined by the
melting temperature (Tm) of each probe. The probes used were ITS1, 5-CTC
TCACCTCACTCCAGACACCTCGCTCCA-3; ITS2, 5-ACCCACCGCAGC
GGGTGACGCGATTGATCG-3; and 28S, 5-CACCTTTTCTGGGGTCTGA
T-3.
Sucrose gradient centrifugation. Sucrose gradient centrifugation for polysome
analysis was performed as previously described (24). One gram of liver tissue, 200
l hypotonic buffer (1.5 mM KCl, 2.5 mM MgCl2, and 5.0 mM Tris-Cl, pH 7.4),
and 200 l hypotonic lysis buffer (1.5 mM KCl, 2.5 mM MgCl2, and 5.0 mM
Tris-Cl, pH 7.4; 2% sodium deoxycholate, 2% Triton X-100, and 2.5 mM dithio-
threitol [DTT]) were gently homogenized using a Dounce homogenizer. The
lysates were centrifuged at 8,000  g for 10 min at 4°C. The supernatant (800
l) was supplemented with 4 l RNase inhibitor (Invitrogen) and 80 l heparin
and stored at 	80°C. Linear 10% to 45% sucrose gradients (80 mM NaCl, 5 mM
MgCl2, 20 mM Tris-Cl, pH 7.4, and 1 mM DTT) were formed using a Gradient
Master (BioComp). Gradients were centrifuged at 38,000 rpm for 3 h at 4°C and
analyzed with an ISCO fractionator (ISCO).
Histology and immunohistochemistry. Liver sections from the age-matched
knockout mice and control littermates were analyzed by hematoxylin and eosin
(HE) staining to count mitotic bodies characteristic of cells in M phase of the cell
cycle. Indirect immunohistochemistry for BrdU was used to identify proliferating
cells in S phase. Terminal deoxynucleotidyltransferase-mediated dUTP nick-end
labeling (TUNEL) was used to detect apoptotic nuclei.
Double staining of dyskerin and fibrillarin or dyskerin and BrdU was used to
determine their expression and/or localization. Briefly, 4-m-thick paraffin sec-
tions were passed through xylene and graded alcohol and rinsed in phosphate-
buffered saline (PBS). Slides were then treated with Diva Decloaking solution
(BioCare Medical, Walnut Creek, CA) in a pressure cooker for 3 min. Slides
were rinsed with PBS three times. Slides were then incubated with primary rabbit
anti-dyskerin antibody (1:200) and mouse antifibrillarin (1:1,000) or with anti-
dyskerin and rat anti-BrdU (1:400; Accurate Chemical & Scientific Corp, West-
bury, NY) overnight at 4°C. After washes, the sections were incubated in the
secondary anti-rabbit Cy3-conjugated antibody (1:500; Jackson ImmunoResearch,
West Grove, PA) and anti-mouse fluorescein isothiocyanate (FITC)-conjugated
antibody (Jackson ImmunoResearch) or with anti-rabbit Cy3 and anti-rat FITC-
conjugated antibody (1:200; Jackson ImmunoResearch) for 1 h at room temper-
ature. Sudan black autofluorescence inhibitor (Chemicon International, Te-
mecula, CA) was used to quench the background fluorescence. Slides were rinsed
with distilled water (dH2O) and counterstained with DAPI (4,6-diamidino-2-
phenylindole). Slides were viewed under an Axioskop 40 (Zeiss) upright
research microscope, and digital images were obtained with a Nikon Coolpix
camera.
The positive cells were counted in 5 low-power fields (200) in 3 sections for
HE, BrdU, and TUNEL staining or a higher-power field (1,000; up to 300 cells)
from 3 different knockout or control livers for double staining.
mRNA processing and quantitative reverse transcription-PCR (qRT-PCR).
The levels of pre-mRNA and mRNA of glyceraldehyde-3-phosphate dehydro-
genase (GADPH) and nucleolin were measured by RT-PCR. 28S was used as a
control. The SYBR green master mix (Applied Biosystems, Foster City, CA) was
used to follow RNA amplification in the real-time reaction. Reverse transcrip-
tion and PCRs were performed according to the manufacturer’s recommenda-
tions for the SuperScript III first-strand synthesis system for RT-PCR (Invitro-
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gen). The primers were specifically designed with Primer Express 3.0 software
(Applied Biosystems). For nucleolin, the forward primer for spliced mRNA was
5-CATGTGACTAAGTCCTTCATGACTGA-3, the forward primer specific
for unspliced pre-mRNA was 5-GGATGGGAAAAGTAAAGGGATTG-3,
and the reverse primer was 5-GCCTTTGACCTTTCTCTCCAGTAT-3. For
GAPDH, the forward primer for spliced mRNA was 5-TTGTGGAAGGGCT
CATGACCACAGTCCA-3, the forward primer for unspliced pre-mRNA was
5-CTCACTCATTGCCCCCGTGTTTTCTA-3, and the reverse primer was 5-
TCAGATCCACGACGGACACATTGGGGG-3. For U2, the forward primer
was 5-TTTGGCTAAGATCAAGTGTAGTATCTGTT-3 and the reverse
primer was 5-CCAACTCCTACTTCCAAAAATCCA-3. For 28S, the forward
primer was 5-GGTAGCCAAATGCCTCGTCAT-3 and the reverse primer was
5-CCCTTGGCTGTGGTTTCG-3. Fluorescence was measured using an Ap-
plied Biosystems 7500 Fast Real-Time PCR system (Applied Biosystems).
Statistical analysis. An unpaired two-tailed Student t test was used to compare
hepatocellular BrdU incorporation, TUNEL staining, mitotic body index, liver
weight-to-body weight ratio, alanine aminotransferase (ALT) activity, and DNA
recombination efficiency with significance set at 0.05.
RESULTS
Dkc1 knockout mouse models. We previously described the
construction of the Dkc1lox allele by gene targeting (19). The
Dkc1lox allele has a lox element in intron 11 and an internal
ribosome entry site (IRES)-Neo selection cassette followed by
a second lox element in the 3 untranslated region (UTR) (Fig.
1A). In the presence of the Cre recombinase, the lox elements
recombine, removing exons 12 to 15, producing the deleted
allele Dkc1DC1. In experiments with mouse embryonic fibro-
blast (MEF) cells (not shown), we do not detect any truncated
protein corresponding to the expected product from the de-
leted allele, and so the Dkc1DC1 allele is essentially a null
allele. Having found that the Dkc1DC1 allele is embryonic
lethal (19), we were interested in whether adult tissues could
survive in the absence of dyskerin. We thus bred male
Dkc1loxTg:Mx1Cre mice, taking advantage of the Mx1 interfer-
on-inducible promoter, which can be conveniently induced by
double-stranded RNA in the form of poly(I:C). After Cre
induction mice were sacrificed at 2 days, 1 week, 1 month, and
3 months, and DNA was extracted from different tissues and
examined by Southern blotting for the proportions of Dkc1lox
and Dkc1DC1 alleles. The results (Fig. 1B and C) show that in
FIG. 1. Deletion of the Dkc1 gene in various tissues of Dkc1loxTg:Mx1Cre transgenic mice at different times. Groups of 4 mice (6 weeks old)
were injected with poly(I:C) (i.p.; 250 g) 3 times every other day. Genomic DNA was prepared from the indicated organs, and Cre-mediated
deletion of the Dkc1 gene was detected by Southern blotting. (A) Diagram of Dkc1 gene and the targeted alleles. The Dkc1lox allele has a lox
element in intron 11 and an IRES Neo selection cassette followed by a second lox element in the 3 UTR. In the presence of the Cre recombinase,
the lox elements recombine, removing exons 12 to 15, producing the deleted allele Dkc1DC1. (B) Southern blotting for the proportions of Dkc1lox
and Dkc1DC1 in various tissues collected 4 weeks after poly(I:C) injection. BM, bone marrow. (C) Quantification of the Dkc1 recombination
efficiency in various tissues of Dkc1loxTg:Mx1Cre mice over time. The surviving cells in liver are more than 80% recombined at the Dkc1 locus, while
those in thymus and bone marrow are only 0 to 20% recombined. (D) Cells in various tissues of female Dkc1lox/ mice consist of 50% deleted
and 50% WT alleles after poly(I:C) treatment, showing that the induction of the deletion is efficient. In this experiment the mice were Dkc1DC7
with differently placed lox sites (19). CER, cerebellum. (E) Western blot showing the decrease in the amount of dyskerin in the liver of 2 mice,
one with a 60% reduction and one with a 90% reduction in the amount of dyskerin. TBP, TATA box binding protein.
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most tissues the proportion of surviving cells containing the
deletion is about 40% (heart and kidney) or close to zero (bone
marrow, thymus, spleen, and lung). In the liver, however, the
proportion of surviving cells is much higher, greater than 80%
in some animals; it reaches a maximum after 2 days, remains
high for 4 weeks, and then slowly falls afterwards. These results
almost certainly arise from competitive outgrowth of the few
cells that escape the Dkc1 deletion populating most of the
adult organs and tissues, as has been seen in experiments
involving the deletion of essential genes in adult mice (46). In
experiments in which female Dkc1lox/ animals were injected,
most tissues consisted of 50% deleted and 50% WT alleles,
indicating that the efficiency of deletion was close to 100% and
the surviving cells were presumably the ones with the WT allele
on the active X chromosome (Fig. 1D). Thus, we conclude that
hematopoietic tissues with high rates of cellular proliferation
cannot survive without dyskerin, while tissues with a lower
proliferative rate, such as the uninjured adult liver, can tolerate
high levels of Dkc1 deletion.
Deletion of Dkc1 in mouse liver. We wanted to investigate in
more detail the induction of the Dkc1 deletion in the liver in
the Dkc1loxTg:Mx1Cre mice after poly(I:C) injection. The pro-
portion of cells with the deletion reached 90% after 2 days and
remained at 90% until 1 month after injection before gradually
decreasing (Fig. 1C). We therefore chose to use livers 1 month
after injection for our studies. The maximum extent of deletion
was variable as measured either by Southern blotting or by
Western blotting. Figure 1E shows the decrease in the amount
of dyskerin in the livers of 2 mice, one with a 60% reduction
and one with a 90% reduction in the amount of dyskerin. The
antibody used in this experiment (38) was raised against a
mixture of 2 peptides, one of which is deleted as part of the
Dkc1DC1 deletion. It is thus possible that a truncated protein
is present in the livers after deletion that is not detected by this
antibody. With a second antibody made against an N-terminal
peptide, however, no truncated peptide is detected (see Fig. S1
in the supplemental material), indicating that if this peptide is
made, it is very unstable.
The loss of dyskerin from the liver in these mice was con-
firmed by immunohistochemistry. In WT hepatocytes dyskerin
colocalizes with fibrillarin as dense spots at the nucleoli, but in
livers from the knockout mice dyskerin is not detectable in
many of the hepatocytes (Fig. 2A). Interestingly, in many hepa-
tocytes lacking dyskerin, fibrillarin is not localized in dense
spots as before. Fibrillarin is a component of C/D box snoRNAs
which participate in methylation of nascent rRNA molecules
during the same stages of rRNA biogenesis in which H/ACA
snoRNAs act (7). To ask if the lack of detectable fibrillarin is
due to destabilization of fibrillarin caused in some way by lack
of dyskerin, we looked at fibrillarin by Western blotting (Fig.
2B). There was no difference between WT and knockout livers,
suggesting that in the absence of dyskerin C/D snoRNPs are
not maintained in nucleoli.
To confirm our result that mice can tolerate lack of dyskerin
in liver and to use a system independent of interferon induc-
tion, we next decided to induce the Dkc1 deletion by using the
Cre recombinase under a liver-specific promoter, i.e., the
mouse albumin promoter, AlbCre (41). We studied the appear-
FIG. 2. Loss of dyskerin and fibrillarin in hepatocyte nucleoli in Dkc1loxTg:Mx1Cre transgenic mice by immunohistochemistry. (A) Dyskerin
localizes to the nucleolus and colocalizes with the C/D snoRNP protein fibrillarin. The liver tissue was paraffin embedded and incubated with rabbit
antidyskerin and mouse antifibrillarin antibody. The nucleoli were counterstained with DAPI. (B) Western blotting showed that the amount of
nuclear fibrillarin protein in the KO mice was not changed. TATA box binding protein (TBP) was used as a loading control.
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ance of the Dkc1 deletion in male Dkc1loxTg:AlbCre mice.
Southern blot analysis showed a peak of 70% of liver cells
containing the deletion at 6 weeks with this level being main-
tained until 12 weeks and then declining (Fig. 3A). Because
AlbCre mice express Cre only in hepatocytes and possibly in
bile duct and hepatocytes make up only about 70% of liver
cells, these calculations underestimate the amount of deletion.
A similar decrease in dyskerin was detected at the protein level
(Fig. 3B). Immunofluorescence with dyskerin and fibrillarin
antibodies was similar to that observed with Dkc1loxTg:Mx1Cre
mice.
Dkc1loxTg:AlbCre mice show signs of chronic liver damage
and impaired rRNA processing. The histology of the livers
depleted of dyskerin by Mx1-Cre induction appeared normal
(data not shown). However, in the livers of Dkc1loxTg:AlbCre
mice at 9 weeks of age marked abnormalities were observed.
These were not present at 6 weeks (data not shown), indicating
that they may develop several weeks after Dkc1 deletion. For
example, these livers exhibited fibrotic regions and small pro-
liferating cells in periportal areas (Fig. 4A). In addition the
liver weight and body weight of the KO mice were significantly
reduced compared with WT mice (Table 1). To further assess
liver damage in these mice, we measured serum ALT activity
and bilirubin. Comparable and normal levels of bilirubin were
observed in the WT and KO mice. However, the KO mice
showed a 3.5-fold increase in serum ALT, indicating the pres-
ence of liver damage. We also used TUNEL staining to mea-
sure the extent of apoptosis in the liver tissue and found that
0.2 to 0.3% of hepatocytes in the knockout livers stained pos-
itive while positive-staining hepatocytes in WT age-matched
animals were virtually undetectable (Fig. 4B). Finally, we per-
formed analysis of hepatocellular BrdU incorporation, which
revealed that 1.3% of hepatocytes in KO mice but less than
0.5% in WT mice incorporated BrdU, reflecting increased
cellular turnover in KO livers (Fig. 4C).
FIG. 4. Dyskerin deletion activates a p53-dependent cell cycle ar-
rest pathway in Dkc1loxTg:AlbCre mice. (A) HE staining of liver section
showing the fibrotic regions and the appearance of small proliferating
cells in the portal areas in KO mice (200). (B) Detection of apoptotic
hepatocytes in KO mice by TUNEL staining (200; P 
 0.05). The
arrows show positive nuclei. (C) Increased hepatocyte proliferation in
KO mice by BrdU staining (200; P 
 0.05). (D) Western blot show-
ing the elevation of p53 and p21 protein in the livers of KO mice.
-Actin was used as a loading control.
TABLE 1. Body weight and liver weight in 9-week-old WT
(Dkc1lox) and KO (Dkc1loxTg:AlbCre) mice
Variable WT KO
Liver wt (g) 1.310  0.045 1.178  0.051a
Body wt (g) 28.503  0.991 24.620  0.629a
Liver/body wt ratio 0.046 0.049
a P 
 0.05.
FIG. 3. Deletion of Dkc1 gene in liver of Dkc1loxTg:AlbCre trans-
genic mice at different times. (A) Dkc1 recombination efficiency in
mice of different ages determined by Southern blot analysis. Liver
DNA was isolated from 5- to 16-week-old mice and subjected to
Southern blot analysis as shown in Fig. 1; the percentage of Dkc1DC1
alleles reached a peak of 70% at 6 to 12 weeks. (B) Western blotting
showed that the dyskerin protein in liver is significantly decreased in
the KO mice. TBP is TATA box binding protein used as a loading
control.
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Because impaired ribosome biogenesis, a possible effect of
dyskerin ablation, is known to promote p53-dependent cell
cycle arrest and apoptosis (33, 40), we next quantified the
expression of p53 and the p53 target p21 in KO and WT livers.
Figure 4D shows increased levels of both proteins in KO liver,
indicating that the p53 cell cycle arrest pathway is activated in
hepatocytes lacking dyskerin.
Together, our observations that lack of dyskerin leads to
mislocalization of fibrillarin (Fig. 2A) and induces a p53-de-
pendent cell cycle arrest (Fig. 4D) suggested that ribosome
biogenesis may be impaired in the hepatocytes lacking dys-
kerin. Although the effect of dyskerin ablation on ribosome
biogenesis in mammalian cells has not been investigated, Cbf5-
deficient yeasts exhibit a complete block in rRNA synthesis (6).
Furthermore, yeast Cbf5 mutants that fail to pseudouridylate
RNA display a growth defect and impaired ribosome produc-
tion but do not show abnormal accumulation of rRNA pro-
cessing intermediates (56). Based on these observations, we
were interested in the effects of dyskerin ablation on rRNA
processing in mouse liver. To investigate this, hepatic rRNA
from Dkc1loxTg:AlbCre mice and their wild-type littermates of
different ages was analyzed by Northern blotting. The results
show that dyskerin deficiency results in changes in the accu-
mulation of rRNA precursors including decreased 21S, 41S,
17S, and 12S RNA. Of the products of the ITS1 cleavage, the
30S species increases while the 32S species is not altered (Fig.
5A and B; see also Fig. S2 in the supplemental material).
Finally we analyzed the polysome profile of WT and KO livers,
which showed a decrease in the relative amount of 80S ribo-
somes in the KO livers (Fig. 5C).
Dkc1loxTg:AlbCre mice exhibit an impaired hepatocellular
proliferative response to acute liver damage. The data de-
scribed above, showing that hepatocytes can survive for months
after Dkc1 deletion, suggest that dyskerin is not essential for
cell survival (Fig. 1B and D). However, the modestly increased
liver damage seen in these mice raises the question of whether
the slow loss of Dkc1-deleted liver cells over time is the result
of a relative proliferative advantage of wild-type hepatocytes
FIG. 5. Dyskerin ablation disrupts rRNA processing in the Dkc1loxTg:AlbCre mice. (A) Scheme of pre-rRNA processing in mouse liver (5). The
probes at ITS1 and ITS2 were used to detect the precursors of 18S and 5.8S, respectively. (B) Northern blot of RNA from livers of male mice of
different genotypes. With the ITS1 probe a decrease in the amount of the 21S and accumulation of the 30S, which are the precursors of the mature
18S RNA, are observed in the KO mice. With the ITS2 probe a decrease in the precursors of 41S, 17S, and 12S was observed. (C) Effect of dyskerin
deletion on polysomes. Polysomes from liver extracts were sedimented through 10 to 45% sucrose gradients, showing a decrease in the amount
of 80S ribosomes but no significant change in the polysome profile. The 40S and 60S subunits were present in wild-type and KO livers in very small
amounts.
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over Dkc1-null cells during the hepatic regenerative response
to such injury. To answer this question, we examined the de-
gree of injury and hepatic regenerative response to CCl4 in
Dkc1loxTg:AlbCre and Dkc1lox mice. Both KO and WT mice
showed comparable perivenous damage (Fig. 6A), indicating
that dyskerin deletion did not affect the susceptibility of liver
cells to CCl4 damage. In contrast, analysis of hepatocellular
BrdU incorporation showed significantly (P 
 0.05) increased
hepatocellular proliferation at 48 and 72 h after CCl4 injection
in WT compared with KO mice (Fig. 6B and C). The reduced
proliferative index in KO cells was further demonstrated by the
significantly diminished mitotic index 72 h after CCl4 treat-
ment in these animals (Fig. 6D). Interestingly, the proportion
of cells that are BrdU positive at 48 h to those in mitosis at 72 h
is the same in WT and KO livers, implying that there is no
block at the G2-M transition in KO mouse hepatocytes. Figure
6B also illustrates the presence of a population of nonparen-
chymal periportal liver cells that are labeled with BrdU. These
cells are much more abundant in KO than WT livers. Although
we have not yet identified them, we suspect that they are
infiltrating immunological cells. These data show that hepato-
cellular proliferation is impaired in Dkc1loxTg:AlbCre mice.
Dyskerin is necessary for cell division. The observation that
hepatocellular proliferation is reduced in Dkc1loxTg:AlbCre
versus control mice and that some hepatocytes in Dkc1loxTg:
AlbCre mice escape the Dkc1 deletion raises the possibility that
the small number of proliferating hepatocytes in the KO livers
were those that escaped deletion. Southern blotting of liver
DNA from the KO livers before and 48 h after the CCl4
treatment shows that the proportion of the Dkc1lox allele ex-
pressing WT dyskerin goes from 30% before to 70% after (Fig.
7A), which is consistent with this possibility. Immunohisto-
chemical analysis showed that 48 h after CCl4 treatment all the
BrdU-positive hepatocytes in Dkc1loxTg:AlbCre mice were pos-
itive for dyskerin expression (Fig. 7B and C). These data pro-
vide convincing evidence that dyskerin is essential for hepato-
cellular proliferation.
mRNA processing in the absence of dyskerin. We have ob-
served that dyskerin can be ablated from a large proportion of
mouse hepatocytes without any overt effect on the health of the
animal. As well as being involved in ribosome biogenesis and
telomere maintenance, dyskerin is involved indirectly in
mRNA splicing, since snRNAs are modified by pseudouridy-
lation guided by H/ACA scaRNAs. Inhibition of mRNA splic-
ing may be expected to cause a more severe phenotype than we
observed. For this reason we wanted to examine mRNA splic-
ing in WT and KO livers (31). We thus chose 2 genes ex-
pressed in liver, GAPDH and nucleolin, and measured the
steady-state levels of unspliced and spliced transcripts in
WT and KO animals, reasoning that the ratio between them
would reflect the efficiency of splicing. The calculated ratio
between spliced and unspliced transcripts did not show any
significant change for either gene, implying that dyskerin
ablation did not affect splicing efficiency (Fig. 8A). This
result was not expected since spliceosomal RNAs, including
U2, contain a high proportion of modified nucleotides and
FIG. 6. Hepatocyte proliferation before and after CCl4 treatment in Dkc1
loxTg:AlbCre mice. (A) Similar perivenous damage in the livers of WT
and KO mice after CCl4 treatment by HE staining (200). (B) Impaired hepatocyte proliferation in the liver of KO mice 72 h after CCl4 treatment
by BrdU staining (200). (C) Quantification of BrdU-positive hepatocytes after CCl4 treatment at different time points. At time zero, BrdU
incorporation was seen in 1.3% of hepatocytes in KO mice but in less than 0.5% of hepatocytes in WT mice. The peak of the response in WT liver
was seen at 72 h with 24.7% hepatocytes positive, but only 6.5% hepatocytes were positive in KO livers (P 
 0.05 at time zero, 48 h, and 72 h).
(D) Decreased mitotic index in the KO hepatocytes due to the poor proliferative response.
VOL. 30, 2010 DYSKERIN ABLATION IN MOUSE LIVER 419
 o
n








in the case of U2 it has been shown in vitro that pseudouri-
dines are required for efficient splicing (10). We thus exam-
ined the steady-state level of U2 RNA in WT and KO livers
by qRT-PCR and found no significant difference (Fig. 8B).
These data indicate that there is no gross defect in mRNA
processing in the absence of dyskerin.
DISCUSSION
Most of our knowledge about dyskerin and snoRNPs and
their role in modification of rRNA and snRNA comes from
genetic studies of yeast and structural studies of archaebacte-
ria. Modification using guide RNAs is a highly conserved pro-
cess, and the proteins associated with H/ACA RNA and C/D
RNAs are also highly conserved (22). In humans mutations in
DKC1 cause X-linked dyskeratosis congenita (20), and there is
good evidence that the major effect of these pathogenic dys-
kerin mutations is to decrease telomerase activity, causing in-
creased telomere shortening and exhaustion of stem cells in
highly proliferating tissues (50). It is possible, however, that
defects in snoRNP function also contribute to X-linked DC
(38, 45). In mice a Dkc1 knockout is embryonic lethal (19),
while other mutations cause variable effects on telomerase
activity and rRNA biogenesis (17, 18, 38, 45). Here we have
used an inducible deletion strategy to knock out Dkc1 in adult
mice. We found that while most tissues could not survive with-
out dyskerin and became populated by cells that had escaped
the deletion, the liver could survive with a large proportion of
its Dkc1 genes deleted for several months. In fact the rate of
turnover of hepatocytes in the livers of knockout animals was
higher than that in wild-type animals. This was most likely due
to the induction of apoptosis in a small percentage of cells and
their replacement by the division of hepatocytes that had, we
presume, escaped the deletion. Deletion in solid tissues using
the Mx1-Cre system is never complete, but since we achieved
the maximum possible efficiency of deletion of about 50% in
Dkc1lox/ females, we assume that the efficiency of deletion in
our mice was high.
Ribosome synthesis is inhibited in the absence of dyskerin.
One of our primary objectives was to determine to what extent
lack of dyskerin affects rRNA processing and ribosome bio-
genesis. Our experiments suggest that in the absence of dys-
FIG. 7. Dyskerin is necessary for cell division. (A) Southern blot of
liver DNA from the Dkc1loxTg:AlbCre mice before and 48 h after the
CCl4 treatment. The proportion of the WT Dkc1
lox allele in the KO
liver goes from 30% before to 70% after (P 
 0.001). (B) Immuno-
fluorescent detection of the presence of BrdU and dyskerin in the
hepatocytes of Dkc1loxTg:AlbCre mice 48 h after treatment with CCl4.
Paraffin-embedded liver sections were double stained with antidys-
kerin and anti-BrdU antibodies, and the nucleoli were counterstained
with DAPI. Hepatocellular BrdU incorporation was correlated with
dyskerin in the dyskerin-null mice. (C) Quantification of dyskerin- and
BrdU-positive hepatocytes. Three hundred hepatocytes were counted,
and all those that had incorporated BrdU were dyskerin positive.
FIG. 8. Dkc1 deletion does not affect mRNA processing. (A) Lev-
els of nucleolin and GAPDH pre-mRNA and mRNA in KO and WT
liver. Dkc1 deletion has no effect on the RNA levels or the pre-mRNA/
mRNA ratio. 28S RNA was used as an internal control. (B) Measure-
ment of U2 RNA levels in KO and WT liver by qRT-PCR.
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kerin ribosome biogenesis cannot proceed. Firstly, in total liver
RNA probed for rRNA precursors by Northern blotting we see
a marked reduction in more mature processed rRNA precur-
sors and also an accumulation of the 30S precursor. In
Dkc1loxTg:AlbCre mice the dyskerin gene is deleted in hepato-
cytes, which comprise about 70% of the liver cells, and as seen
in the immunofluorescence experiments, some hepatocytes es-
cape the deletion. Therefore, a decrease in the amount of an
RNA precursor likely means that it is absent in cells with the
deletion. This assumption is supported by the differences in the
rRNA processing pattern between Alb-Cre and Mx1-Cre exper-
iments. With the Dkc1loxTg:Mx1Cre mice after poly(I:C) treat-
ment, the dyskerin deletion extends to nonhepatocytes, and in
these experiments, we see a more extreme change in the pat-
tern of rRNA processing (data not shown). The precise nature
and sequence of processing events that take place during the
maturation of the primary 47S transcript to the mature 18S,
5.8S, and 28S rRNAs in mouse are not completely established
(27, 47). However, two alternative early events are cleavage in
the 5 external transcribed spacer (ETS) to give a 41S precur-
sor or cleavage within ITS1 to give a 30S and a 32S RNA. Very
little 41S RNA is detected in KO livers, suggesting that dys-
kerin is required for the early cleavage event in the 5 ETS
(27). The 30S and 32S precursors in normal mouse cells are
further processed, 30S being processed via a 21S intermediate
to mature 18S RNA and 32S being processed via 17S and 12S
intermediates to mature 5.8S RNA. The probes that we used
(Fig. 5) hybridize to the 30S, 32S, 17S, 12S, and 21S species and
show that while the early products of ITS1 cleavage accumu-
late, the amount of 12S, 17S, and 21S intermediates is reduced
in KO compared with WT livers. Together these data suggest
that in the absence of dyskerin the initial ITS1 cleavage event
takes place but the 30S and 32S precursors are not processed
further, indicating that further processing requires pseudouri-
dylation of the nascent transcripts and/or an H/ACA RNA-
dependent cleavage event. Pseudouridylation of rRNA is
thought to take place on the early transcripts, prior to cleavage
in ITS1 (4, 11). Our results are compatible with recent studies
showing that while most cleavage events in rRNA processing,
including those in the 5 ETS, require the participation of
snoRNPs, a cleavage site within ITS1 requires, at least in yeast,
only the action of the catalytic RNA RNase MRP (23, 30).
More compelling evidence that ribosome biogenesis is
halted in cells without dyskerin is our observation that in these
cells immunofluorescence with a fibrillarin antibody does not
show a brightly staining nucleolus as seen in wild-type cells.
Fibrillarin is the active methylase present in C/D snoRNPs,
and in ribosome biogenesis it is active on the same molecules
as is dyskerin. These molecules will not become pseudouridy-
lated in the absence of dyskerin, and our results suggest that
lack of pseudouridylation affects the action of C/D snoRNAs.
The mechanism underlying the apparent linkage between
these 2 processes will be the subject of further experiments—
it will be interesting to know if lack of methylation inhibits
pseudouridylation. Moreover, the factors that maintain snoRNPs
in the nucleolus may be amenable to analysis in this system.
Dyskerin is essential for cell division. The second major
finding from our experiments is the absence of any cell division
in cells with no dyskerin. The dyskerin-depleted livers that we
studied showed a much-reduced proliferative response to liver
damage induced by CCl4. Moreover, regeneration was accom-
panied by an increase in the relative amount of wild-type DNA
compared with DNA containing the Dkc1 deletion, indicating
that much of the regeneration had involved division of cells
that did not contain a deleted gene. Compelling evidence that
absence of dyskerin is incompatible with cell division is our
observation that when Alb-Cre mice were treated with CCl4
and allowed to recover from the resulting liver damage very
few cells in the knockout livers were replicating their DNA as
assessed by BrdU incorporation. Remarkably the few cells that
did incorporate BrdU were all among the minority of cells in
the livers that stained positive with the dyskerin antibody.
Presumably these were cells that had escaped the deletion.
Whether the block in the cell cycle is caused by nucleolar
disruption activating the p53 checkpoint response (39, 41) or is
due to an unknown mechanism that couples cell division and
ribosome biogenesis (2, 41) remains to be determined.
Conclusions. Using conditional deletion of the mouse Dkc1
gene in hepatocytes, we have produced a model in which we
can study mammalian cells without any dyskerin. This model
should prove useful in delineating the role of dyskerin and
H/ACA snoRNAs in ribosome biogenesis, telomere mainte-
nance, and mRNA expression. Furthermore, the influence of
ribosome biogenesis on cell cycle progression may be amena-
ble to experimentation using this model. The experiments pre-
sented here show that lack of dyskerin blocks rRNA processing
after cleavage of the primary transcript in ITS1 and leads to
disruption of ribosome biogenesis. In the absence of dyskerin,
hepatocytes are not able to divide.
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